LENSAR, Inc. cotiza a 6.27 USD y tiene una capitalización bursátil de $77M. En los últimos 12 meses ha facturado $60M con un margen de flujo de caja libre del -25.5%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the …
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | — | $-0.20 | $-0.11 |
| Estimado | $-0.14 | $-0.27 | $0.49 | $-0.10 |
| Sorpresa | — | — | -140.8% | -10.0% |
| Métrica | LNSR | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 46.4% | 57.0% | -10.6% |
| Operating Margin | -42.1% | -38.6% | -3.4% |
| Net Margin | -58.7% | -33.6% | -25.1% |
| FCF Margin | -25.5% | -13.9% | -11.7% |
| ROE | — | -40.4% | — |
| ROA | -48.0% | -32.0% | -16.0% |
| Current Ratio | 1.15 | 2.84 | -1.69 |
| Debt / Equity | — | 0.28 | — |